In the context of diabetes, Lv et al. demonstrated that simvastatin can inhibit activation of NLRP3 inflammasome in vascular endothelial cells thereby protecting against hyperglycemia-induced endothelial dysfunction and improving vascular permeability [315]. This evidence concerns the gene NLRP3 and diabetes mellitus.